VPC

Vestal Point Capital Portfolio holdings

AUM $2.73B
1-Year Est. Return 128.57%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+128.57%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$2.73B
AUM Growth
+$522M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
105
New
Increased
Reduced
Closed

Top Buys

1
+$134M
2
+$118M
3
+$104M
4
ABVX
Abivax
ABVX
+$98.2M
5
MRK icon
Merck
MRK
+$72.7M

Top Sells

1
+$104M
2
+$87.8M
3
+$76.8M
4
IONS icon
Ionis Pharmaceuticals
IONS
+$70.3M
5
BDX icon
Becton Dickinson
BDX
+$60.8M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FOLD icon
76
Amicus Therapeutics
FOLD
$4.51B
– –
-9,750,000
GSK icon
77
GSK
GSK
$107B
– –
-125,000
INSP icon
78
Inspire Medical Systems
INSP
$1.68B
– –
-135,000
IONS icon
79
Ionis Pharmaceuticals
IONS
$11.8B
– –
-1,075,000
KOD icon
80
Kodiak Sciences
KOD
$1.42B
– –
-250,000
LUNG icon
81
Pulmonx
LUNG
$69.3M
– –
-830,000
QQQ icon
82
Invesco QQQ Trust
QQQ
$384B
– –
0
QURE icon
83
uniQure
QURE
$971M
– –
-225,000
RARE icon
84
Ultragenyx Pharmaceutical
RARE
$2.06B
– –
-750,000
RCUS icon
85
Arcus Biosciences
RCUS
$2.75B
– –
-250,000
REGN icon
86
Regeneron Pharmaceuticals
REGN
$78.8B
– –
-25,000
VTYX
87
DELISTED
Ventyx Biosciences
VTYX
– –
-2,050,000
TRAW icon
88
Traws Pharma
TRAW
$16M
– –
-150,000
TVRD
89
Tvardi Therapeutics
TVRD
$36.8M
– –
-167,000
APLT
90
DELISTED
Applied Therapeutics
APLT
– –
-14,250,000
ARQT icon
91
Arcutis Biotherapeutics
ARQT
$2.82B
– –
-200,000
ATXS
92
DELISTED
Astria Therapeutics
ATXS
– –
-4,956,000
BDX icon
93
Becton Dickinson
BDX
$45.3B
– –
-325,000
BHVN icon
94
Biohaven
BHVN
$1.44B
– –
0
BIIB icon
95
Biogen
BIIB
$26.6B
– –
-275,000
BLTE
96
Belite Bio
BLTE
$6.46B
– –
-312,500
BRKR icon
97
Bruker
BRKR
$5.14B
– –
-440,000
CDTX
98
DELISTED
Cidara Therapeutics
CDTX
– –
-400,000
CGON icon
99
CG Oncology
CGON
$5.43B
– –
-175,000
CRNX icon
100
Crinetics Pharmaceuticals
CRNX
$3.93B
– –
-750,000
1 2 3
4
5